Complement C1 Inhibitor Protein [inhibiční protein komplementu C1]
- Terms
-
C1-INH protein
inhibitor C1 esterázy
komplement C1 - inhibiční protein
komplement C1 - inhibitor
SERPING1
-
C1 Esterase Inhibitor
C1-INH Protein
C1-Inhibitor Protein
Complement C1-Inhibitor Protein
Plasma Protease C1 Inhibitor
Serpin Family G Member 1
Serpin G1
SERPING1
An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II.
- Annotation
- do not confuse with COMPLEMENT C1 INACTIVATOR PROTEINS
- DUI
- D050718 MeSH Browser
- CUI
- M0476632
- Previous indexing
- Complement C1 Inactivator Proteins (1970-2005)
- History note
- 2006; for C1 ESTERASE INHIBITOR use COMPLEMENT C1 INACTIVATOR PROTEINS 1970-2005
- Public note
- 2006; for C1 ESTERASE INHIBITOR see COMPLEMENT C1 INACTIVATOR PROTEINS 1979-2005
Combination
- deficiency
- Hereditary Angioedema Types I and II
Allowable subheadings
- AD
- administration & dosage 17
- AE
- adverse effects 7
- AG
- agonists 0
- AN
- analysis 3
- BI
- biosynthesis 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 1
- CL
- classification 0
- DE
- drug effects 0
- EC
- economics 1
- GE
- genetics 7
- HI
- history 0
- IM
- immunology 1
- IP
- isolation & purification 0
- ME
- metabolism 4
- PK
- pharmacokinetics 1
- PD
- pharmacology 6
- PH
- physiology 1
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 29
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0